Tatsuya Higashi Selected Research

2,2-dimethyl-beta-alanine

12/2018	Direct comparison of 2‑amino[3‑11C]isobutyric acid and 2‑amino[11C]methyl‑isobutyric acid uptake in eight lung cancer xenograft models.
1/2018	Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging.
6/2017	Relationship between [14C]MeAIB uptake and amino acid transporter family gene expression levels or proliferative activity in a pilot study in human carcinoma cells: Comparison with [3H]methionine uptake.
1/2017	Discrepancy between radiological and histological findings in ganglioglioma of the optic chasm: Case report.
10/2016	(11)C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with (18)F-fluorodeoxyglucose PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuya Higashi Research Topics

Disease

68	Neoplasms (Cancer) 09/2022 - 02/2002
14	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022 - 02/2002
8	Neoplasm Metastasis (Metastasis) 12/2020 - 06/2003
8	Hepatocellular Carcinoma (Hepatoma) 02/2018 - 09/2006
7	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 04/2004
5	Hypoxia (Hypoxemia) 05/2022 - 10/2017
5	Lung Neoplasms (Lung Cancer) 12/2018 - 12/2004
4	Pheochromocytoma 09/2022 - 01/2018
4	Brain Neoplasms (Brain Tumor) 05/2022 - 01/2017
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2018
4	Carcinoma (Carcinomatosis) 02/2021 - 04/2004
4	Vitamin D Deficiency 03/2017 - 04/2011
4	Atherosclerosis 01/2016 - 01/2011
3	Hyperaldosteronism (Conn Syndrome) 01/2022 - 08/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 10/2016
3	Stomach Neoplasms (Stomach Cancer) 07/2020 - 02/2009
3	Body Weight (Weight, Body) 07/2019 - 06/2018
3	Leukemia 01/2017 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 11/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2013 - 01/2011
3	Seizures (Absence Seizure) 01/2013 - 01/2010
2	Synovial Sarcoma (Synovioma) 02/2022 - 07/2018
2	Malignant Mesothelioma 01/2021 - 05/2019
2	Mesothelioma 01/2021 - 05/2019
2	Melanoma (Melanoma, Malignant) 11/2020 - 01/2020
2	Weight Loss (Weight Reduction) 10/2020 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 09/2020 - 10/2017
2	Esophageal Neoplasms (Esophageal Cancer) 03/2020 - 10/2019
2	Lymphoma (Lymphomas) 10/2018 - 01/2018
2	Amyloid Plaque 05/2018 - 04/2018
2	Hyperthyroidism 01/2018 - 02/2007
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 01/2009
2	Colorectal Neoplasms (Colorectal Cancer) 06/2017 - 01/2007
2	Stroke (Strokes) 08/2012 - 03/2011

Drug/Important Bio-Agent (IBA)

13	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 03/2003
9	Pharmaceutical PreparationsIBA 12/2020 - 05/2009
9	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 02/2002
6	Superoxides (Superoxide)IBA 01/2022 - 10/2016
6	Amino Acids FDA Link 12/2018 - 11/2013
6	Fluorine-18IBA 01/2012 - 06/2003
5	NAD (NADH)IBA 01/2022 - 01/2020
5	Radioisotopes (Radionuclides)IBA 12/2020 - 09/2003
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
5	2,2-dimethyl-beta-alanineIBA 12/2018 - 10/2016
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 08/2016
4	AntibodiesIBA 05/2022 - 04/2005
4	IntegrinsIBA 12/2020 - 04/2017
4	Amyloid (Amyloid Fibrils)IBA 01/2020 - 04/2018
4	Oxygen (Dioxygen)IBA 01/2019 - 12/2009
4	AcidsIBA 12/2018 - 11/2013
4	Methionine (L-Methionine)FDA Link 01/2018 - 12/2004
4	hydroxide ionIBA 03/2017 - 04/2011
4	IodineIBA 02/2012 - 04/2004
3	Vitamin K 3 (Menadione)FDA Link 01/2022 - 01/2020
3	Succinic Acid (Succinate)IBA 01/2022 - 01/2020
3	AldosteroneIBA 01/2022 - 08/2018
3	Thromboplastin (Tissue Factor)IBA 01/2022 - 12/2018
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 09/2021
3	Cetuximab (Erbitux)FDA Link 10/2021 - 06/2018
3	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2010
3	RadiopharmaceuticalsIBA 07/2019 - 04/2004
3	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2016
3	Therapeutic UsesIBA 01/2018 - 09/2003
3	GABA-A Receptors (GABA(A) Receptor)IBA 01/2012 - 12/2009
3	AndrogensIBA 09/2009 - 11/2006
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2009 - 01/2007
3	HexokinaseIBA 04/2007 - 02/2002
2	benzylguanidineIBA 09/2022 - 01/2021
2	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 05/2022 - 02/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 01/2022
2	Drug CombinationsIBA 01/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
2	Glycoproteins (Glycoprotein)IBA 12/2020 - 05/2019
2	64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4IBA 12/2020 - 06/2018
2	Immunoglobulin G (IgG)IBA 10/2020 - 07/2020
2	Monoclonal AntibodiesIBA 01/2020 - 09/2018
2	Cytochromes b5 (Cytochrome b5)IBA 01/2020 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 01/2020 - 01/2020
2	Contrast MediaIBA 01/2020 - 01/2018
2	Free RadicalsIBA 01/2020 - 01/2020
2	1-(3-astatobenzyl)guanidineIBA 07/2019 - 01/2018
2	TEMPOIBA 05/2019 - 10/2016
2	Messenger RNA (mRNA)IBA 12/2018 - 10/2011
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2018 - 06/2017
2	arginyl-glycyl-aspartic acidIBA 06/2018 - 04/2017
2	cyclic arginine-glycine-aspartic acid peptideIBA 06/2018 - 04/2017
2	benzofuranIBA 05/2018 - 04/2018
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 05/2011
2	Thyrotropin Alfa FDA LinkGeneric 01/2018 - 11/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 10/2011
2	MelatoninIBA 10/2017 - 01/2017
2	Calcifediol (Calcidiol)FDA Link 03/2017 - 06/2016
2	Everolimus FDA Link 01/2017 - 11/2016
2	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 01/2017 - 11/2016

Therapy/Procedure

25	Therapeutics 07/2022 - 04/2004
10	Radioimmunotherapy 05/2022 - 11/2017
9	Radiotherapy 01/2022 - 09/2003
4	Drug Therapy (Chemotherapy) 01/2022 - 07/2006
2	Operative Surgical Procedures 10/2021 - 06/2003